Treatment of Chronic Atrophy Gastritis of Rats with Montmorillonites from Different Sources

Liangjing Wang
2007-01-01
Abstract:Objective: To compare therapeutic effects of montmorillonites from five origins on chronic atrophy gastritis(CAG)in rats.Methods:80 male SD rats were randomly assigned into one of eight groups(n=10 each): normal control group,CAG control group,CAG rats treated with sucralfate or five montmorillonites.The CAG model of rats was set up using the Si's method.The CAG rats were treated with sucralfate(312.5 mg·kg-1) or five montmorillonite suspensions(800 mg·kg-1 each) per day for 4 weeks.The rats were sacrificed under anesthesia after the treatment to analyze the pathohistological episodes and the hexosamine levels in the rats' gastric mucus.Results: The rats with CAG showed more reductions of ratio of the thickness of gastric mucosal gland to muscularis mucus(L1/L2 ratio),density of mucosal gland and hexosamine level and escalation of inflammatory index than the normal control rats(P0.05).The montmorilonite-treated rats had better prognosis in improvement of the thickness of gastric mucus,the density of mucosal gland and the hexosamine levels than the rats treated with sulcralfate(P0.05).The Pearson correlation analysis disclosed that montmorillonite with higher layer charge density offered better prognosis(P0.05).Conclusion: The effectiveness of montmorillonite for the treatment of CAG seemed positive proportion to the average layer charge density of montmorillonite.
What problem does this paper attempt to address?